Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

ACET
Adicet Bio Inc
stock NASDAQ

At Close
9/28/2023 3:59:50 PM EDT
1.43USD-1.042%(-0.02)181,155
1.14Bid   1.71Ask   0.57Spread IEX
Pre-market
9/28/2023 8:36:30 AM EDT
1.40USD-2.778%(-0.04)0
After-hours
9/13/2023 4:00:30 PM EDT
1.66USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
61.369M
Headquarters
Boston, Massachusetts, USA
Industry
Biotechnology
Next Earnings
2023-11-07 (40d)
Last Split
2020-09-161for7reverse
Related
IPHSNVSCBMPFEKWRMRKTEVAMYLTLGTXLV
ACET Stats
Avg. Vol. 10 Day
334,976
Avg. Vol. 30 Day
451,834
Employees
132
Market Cap
61,369,275
Shares Out.
43,066,158
Float
23,231,892
On/Off Exchange
41%/59%
6 Month Beta
0.12
1 Year Beta
0.81
2 Year Beta
1.38
3 Year Beta
1.33
52 Week Low
1.45
52 Week High
21.87
SMA50
1.85
SMA200
4.28
1 Week
-7.47%
1 Month
-14.67%
3 Month
-46.02%
6 Month
-74.19%
1 Year
-90.22%
2 Year
-82.96%
5 Year
-98.66%
Profile
adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating tcr-like mabs (tcrls) directed to these cancer-specific peptide targets presented by mhc class i complexes. these tcrls can be used to arm t cells, as t cell engagers or as antibody drug conjugates (adc). in august 2016, adicet entered a strategic collaboration with regeneron pharmaceuticals, inc. to develop next-generation engineered immune-cell therapeutics using adicet's gamma delta t cell allogeneic platform technology. adicet bio raised $51m in series a financing led by orbimed partners, orbimed israel, novartis v

ACET Stock Summary

Adicet Bio Inc (NASDAQ:ACET) stock price today is $1.43, and today's volume is 181,155. ACET is down -1.042% today. The 30 day average volume is 451,834. ACET market cap is 61.369M with 43,066,158 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC